Moderna - A Step Closer To Coronavirus Vaccine: ETFs To Gain
June 14, 2020 at 16:44 PM EDT
The first company to start human clinical trials of its coronavirus vaccine candidate in the United States — Moderna — has informed that it is on schedule to initiate the final-stage clinical trial by July.